Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Rang în acțiuni #378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Preț acțiune
$40.26
Capitalizare de piață
$64.06B
Schimbare (1 zi)
0.71%
Schimbare (1 an)
42.44%
Țară
JP
Tranzacționează Takeda Pharmaceutical Company Limited (4502)

Categorie

Healthcare
Istoricul randamentului dividendelor pentru Takeda Pharmaceutical Company Limited (4502)
Randamentul dividendelor (TTM) pentru Takeda Pharmaceutical Company Limited (simbol acțiune: 4502) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Takeda Pharmaceutical Company Limited (4502) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente